Sustainable Endotoxin Testing in China: Chromogenic Assay from Reliable Suppliers and Factory-Grade rCR Solutions
Products Features
The Recombinant Cascade Reagent (RCR) represents a significant advancement in bacterial endotoxin testing, serving as a sustainable and highly specific recombinant alternative to traditional Limulus Amoebocyte Lysate (LAL). Its development aligns with modern ethical and regulatory expectations while maintaining robust analytical performance.
Sustainable & Animal-Free
By utilizing recombinant technology, RCR eliminates dependency on horseshoe crab blood, supporting conservation efforts and promoting animal welfare without compromising reagent supply. The cascade—comprising recombinant Factor C, Factor B, and proclotting enzyme—ensures a mechanism mirroring native LAL.
Enhanced Specificity
Unlike native LAL reagents, RCR is not activated by (1→3)-β-D-glucans, which are known to cause false-positive results in certain samples. This attribute significantly improves test accuracy and reliability in complex pharmaceutical matrices.
Regulatory Compliance
The use of RCR is supported by emerging pharmacopeial standards, such as the proposed USP <86> chapter titled "Bacterial Endotoxins Test Using Recombinant Reagents," facilitating its adoption in regulated laboratory environments.
Finally, the applicability of RCR has been demonstrated across a range of real-world pharmaceutical products, where it has exhibited excellent sample compatibility and produced results comparable to those obtained with traditional LAL-based methods. This proven performance, combined with its ethical and regulatory advantages, positions RCR as a modern and responsible choice for endotoxin testing in the pharmaceutical industry.
Frequently Asked Questions
What is Recombinant Cascade Reagent (RCR)?
RCR is a sustainable, animal-free, and highly specific recombinant alternative to traditional Limulus Amoebocyte Lysate (LAL) used for bacterial endotoxin testing in the pharmaceutical industry.
How does RCR protect horseshoe crabs?
RCR is produced entirely through recombinant technology, eliminating the need for horseshoe crab blood. This supports ecological conservation efforts and animal welfare while securing a stable reagent supply.
Does RCR eliminate false-positive results?
Yes. Unlike native LAL, RCR is not activated by (1→3)-β-D-glucans, which prevents false-positive reactions and ensures higher test specificity in complex pharmaceutical matrices.
Is RCR compatible with existing LAL methods?
Yes, RCR utilizes a recombinant cascade (Factor C, Factor B, and proclotting enzyme) that closely mirrors the reaction mechanism of native LAL, producing highly comparable results.
What regulatory standards support the use of RCR?
RCR is supported by emerging global pharmacopeial standards, including the proposed USP <86> chapter, "Bacterial Endotoxins Test Using Recombinant Reagents," making it suitable for regulated environments.